
Product imagery is intended solely for illustrative purposes. Actual medication packaging and pharmacy labeling may differ.
Weight Management
Semaglutide
A clinician-guided weight-management program built around your history, not a one-size plan.
$399
1-month supply · All-inclusive program price
- Online licensed-provider review
- Secure medical intake after checkout
- Ongoing program support by secure message
- Standard shipping
- Routine follow-up required by the program
May be compounded — not FDA-approved
Available in eligible states. Availability varies by program and pharmacy coverage.
VitaWellRx® notice. VitaWellRx® is a telehealth platform that connects eligible patients with independent US-licensed providers and licensed pharmacy partners. VitaWellRx® is not a pharmacy and does not itself practice medicine. Prescription products are provided only if clinically appropriate after review by a US-licensed provider.
About this program
The VitaWellRx® Semaglutide program is a clinician-guided weight-management program. You choose the program and complete checkout first; the required secure medical intake follows, and a licensed clinician then decides whether treatment is medically appropriate for you.
Semaglutide belongs to a class of medicines known as GLP-1 receptor agonists. Where a compounded formulation would be used, that is disclosed before fulfilment.
You submit your intake, identification, and any requested information for licensed-clinician review. Depending on your location and clinical needs, a real-time video or phone consultation may be required before any prescription decision.
People commonly considered for review include adults with weight-related health goals who can safely be managed remotely. Provider judgment governs.
How it may work
GLP-1 receptor agonists act on pathways involved in appetite signalling and gastric emptying. In general terms, that is why people in clinical settings often report feeling full sooner and staying full longer.
The effect is not automatic and is not identical between people. VitaWellRx® does not publish dosing instructions or self-administration guidance on this website.
Product status
- The program shown here may involve a compounded formulation, which is not FDA-approved.
- Any program would be used only where clinically and legally appropriate.
Eligibility and provider review
Tell your reviewing clinician about personal or family history of medullary thyroid carcinoma or MEN 2, pancreatitis, gallbladder disease, diabetic retinopathy, severe gastrointestinal disease, pregnancy or breastfeeding, and every medication and supplement you take.
Prescription required. Licensed-provider review required. Not everyone qualifies.
Safety summary
- Commonly described side effects of GLP-1 medicines include nausea, vomiting, diarrhoea, constipation, and abdominal discomfort, particularly early in a program.
- Serious risks have been described with this class, including pancreatitis, gallbladder problems, kidney injury related to dehydration, and low blood sugar when combined with certain diabetes medicines.
- This is a high-level summary and not a complete list. Stop and seek immediate care for severe abdominal pain, persistent vomiting, or signs of an allergic reaction.
